Active Shortage Injection Endocrinology/Metabolism

Sodium Bicarbonate Injection · 3,336 days since initial FDA posting

Brand: SODIUM BICARBONATE

FDA lists Sodium Bicarbonate Injection as Active Shortage (Fresenius Kabi USA, LLC).

Availability on file: Unavailable

Sodium Bicarbonate Injection: Active Shortage

Unavailable Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Sodium Bicarbonate Injection
Manufacturer
Fresenius Kabi USA, LLC
Dosage Form
Injection
Presentation
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)
Package NDC
63323-083-05

Status & Timeline

Status
Active Shortage
Availability
Unavailable
First Reported
Jul 24, 2017
Last Updated
Mar 17, 2026
Therapeutic Category
Endocrinology/Metabolism, Gastroenterology, Pediatric

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Expected recovery: TBD

Nearby, Other Sodium Shortage Records

Sodium Bicarbonate Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

Sodium Bicarbonate Injection

Hospira, Inc., a Pfizer Company

Injection

Active Shortage

Sodium Bicarbonate Injection

Hospira, Inc., a Pfizer Company

Injection

Active Shortage

Sodium Bicarbonate Injection

Hospira, Inc., a Pfizer Company

Injection

Active Shortage

Sodium Bicarbonate Injection

Hospira, Inc., a Pfizer Company

Injection

Active Shortage

Sodium Bicarbonate Injection

Hospira, Inc., a Pfizer Company

Injection

Active Shortage

FDA reason on file: Expected recovery: TBD. General shortage guidance lives on the tracker hub.

← All Drug Shortages